Don Davis PhD, MBA

Digital Marketer & Process Improvement NERD - I help companies improve their systems and processes, amplify their voice, increase awareness and drive leads.

Most B2B marketing generates noise. Ours generates pipeline.

I help High Tech and Life Sciences CEOs cut through the chaos and build marketing systems that predictably convert visibility into qualified leads—without the guesswork.

After decades leading digital strategy and P&L in life sciences and operations, I've seen the same pattern: smart teams drowning in tactics that look busy but don't move numbers. They chase trends. We build engines.

Here's what I know: Your buyers aren't hiding. They're ignoring you because your marketing doesn't earn their time.

That's why I founded D3 Digital Media Marketing and created WAVES—a retained, end-to-end growth system designed for B2B companies scaling to $250M. We don't do campaigns. We build compounding systems that create sales conversations.

The WAVES framework (simplified):

• Website as a sales tool – Clear messaging, zero friction, built to convert
• Advanced SEO – Own buyer intent. 2-3x traffic that actually qualifies
• Video + live events – Turn your experts into demand generators
• Social that sells – Content that starts conversations with decision-makers, not engagement farmers
• Strategic PR – Credibility where it counts

Every 90 days, we measure what moves pipeline and eliminate what doesn't. No vanity metrics. No "let's try this." Just disciplined execution and clear ROI.

Why clients choose us: They arrive overwhelmed by options and underwhelmed by results. They leave with a system that compounds—attention that turns into appointments, content that builds trust, and marketing that finally justifies its budget.

If you're a CEO or CMO tired of marketing theater and ready for marketing that funds itself, let's map your next 90 days. I'll show you exactly where the gaps are and how we'll fill them.

📩 Message me. Let's turn your visibility into revenue.

Founder

We help our clients amplify their voice so that they can: create well qualified leads, increase awareness and attract investors.

Paul Smith

Data Integrity 🔐 Critical Thinking I USP <1058> 📜 Laboratory Compliance Thought Leader 🥼 and Consultant (USP 📖<1220>, USP <854>, USP <621>, GAMP 5)

A problem solver, mentor, presenter & writer ☎️ +44 7894 919 828... 

I share KNOWLEDGE, DATA, TRENDS and REGULATORY insight 📈.

Companies can be PRO-ACTIVE or REACTIVE in how they manage KNOWLEDGE and value regulatory insight. PRO-ACTIVE companies treasure it, they evolve to enhance operations and use data to reduce time and regulatory risk. REACTIVE companies tend to WAIT, focus on efficiency over risk and can only invest when they have to (e.g. an FDA 483, or worse....). Specific examples of non-compliance findings - are needed.

SO WHAT, "it's only an FDA 483" - why is that important ?

Costs for 483 remediation are estimated between $250,000 to $1.5 million. Even worse, a Warning Letter may costs 15 % of your annual business revenue or more (𝘵𝘩𝘦 15 % "𝘙𝘶𝘭𝘦"). 

- Why is it hard for labs to be compliant ?

Different tests, set points and diverse qualification protocols by each vendor contributes to a poor global understanding of compliance requirements, and a lack of compliance strategy. Guidance documents such as USP <1058> and GAMP Good Practice Guides have to be interpreted.
 
WHY - I CAN HELP YOU
40+ years of implementing solutions that pass regulatory audits. 

I provide strategic oversight and compliance thought leadership. Instrument Qualification (collaborating with vendors and service providers) to leverage the latest  FDA regulatory insights and help laboratories be compliant. I apply my data integrity training and qualification expertise to address this need.

I have over 100 Recommendations and 2,000 skill endorsements.

As a WRITER - I create impactful content:

- Brochures / Flyers
- Presentations / Trends
- Publications / Reports
- Training / Workshops
- Videos / Webinars 

WHAT - is Data Integrity ?
Applying meaningful interpretations of the core ALCOA+ principles to workflow mapping - key to Data Integrity compliance. I trained with Peter Baker and Monica Cahilly, applying a Data Integrity focus from 2011 (an early adopter). 

WHY - Trend FDA Data ? 
Quality and Transparency - to understand current FDA thinking and learn from others' mistakes. Analysing and trending FDA data creates compliance insight and thought leadership. 

WHY - USE USP <1058> ?
Instrument Qualification is the scientific foundation of data quality. USP <1058> it is the only major pharmacopoeia general chapter on Analytical Instrument Qualification. Satisfying the life-cycle framework of<1058> simplifies Lab audits, because it ensures instruments are suitable for their intended use.

REACH OUT - to contact me........ 
   
☎️+𝟰𝟰  𝟳𝟴𝟵𝟰 𝟵𝟭𝟵 𝟴𝟮𝟴.

GLOBAL COMPLIANCE MARKETING SPECIALIST (USP <1058>)

This role is an evolution of my global compliance focus, as it enables me to design regulatory insights into Agilent compliance marketing documents. An increasingly important part of my Agilent work is to monitor lab. compliance change, such as updates to USP <1058> on Analytical Instrument Qualification, GAMP 5 2nd Edition and non-compliance findings such as Data Integrity, FDA Warning Letters, Lab. compliance trends and other data.

It’s in my DNA to “CONNECT the DOTS” and CONNECT People – I see patterns, trends, and deep compliance insights in regulatory data, which I share through Webinars and training. I design and build analytics tools which help me explore relationships in the information - to achieve this deep insight.

I access much of this information through:

► FDA Data Dashboards
► FDA Inspection Observations
► Health Canada (the "fastest" regulator !)
► REDICA subscription service.

taplio

The Battle

Don Davis PhD, MBA

Paul Smith

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?